Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.

Tuberculosis is the leading cause of death worldwide from infectious diseases. With the development of drug-resistant strains of Mycobacterium tuberculosis, there is an acute need for new medicines with novel modes of action. Herein, we report the discovery and profiling of a novel hydantoin-based family of antimycobacterial inhibitors of the decaprenylphospho-β-d-ribofuranose 2-oxidase (DprE1). In this study, we have prepared a library of more than a 100 compounds and evaluated them for their biological and physicochemical properties. The series is characterized by high enzymatic and whole-cell activity, low cytotoxicity, and a good overall physicochemical profile. In addition, we show that the series acts via reversible inhibition of the DprE1 enzyme. Overall, the novel compound family forms an attractive base for progression to further stages of optimization and may provide a promising drug candidate in the future.

[1]  D. Schnappinger,et al.  Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase , 2018, Journal of medicinal chemistry.

[2]  P. Murumkar,et al.  Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis. , 2018, Journal of medicinal chemistry.

[3]  Robert H Bates,et al.  Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides. , 2016, Journal of medicinal chemistry.

[4]  G. Besra,et al.  Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase. , 2015, ACS infectious diseases.

[5]  S. Cole,et al.  DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization. , 2015, ACS chemical biology.

[6]  S. Mandlekar,et al.  Electrophilicity of pyridazine-3-carbonitrile, pyrimidine-2-carbonitrile, and pyridine-carbonitrile derivatives: a chemical model to describe the formation of thiazoline derivatives in human liver microsomes. , 2014, Chemical research in toxicology.

[7]  Yonggang Chen,et al.  Suzuki-Miyaura cross-coupling reactions of unprotected haloimidazoles. , 2014, The Journal of organic chemistry.

[8]  S. Boyd,et al.  A new and versatile synthesis of 3-substituted oxetan-3-yl methyl alcohols , 2014 .

[9]  Z. Kałuża,et al.  Synthesis of tunable diamine ligands with spiro indane-2,2′-pyrrolidine backbone and their applications in enantioselective Henry reaction. , 2014, The Journal of organic chemistry.

[10]  Vijay T. Ahuja,et al.  Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo. , 2013, Journal of medicinal chemistry.

[11]  Peter G. Schultz,et al.  University of Birmingham Identification of a small molecule with activity against drug-resistant and persistent tuberculosis , 2013 .

[12]  N. Loman,et al.  Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3 , 2013, PloS one.

[13]  Richard J. Marhöfer,et al.  Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach. , 2013, Journal of medicinal chemistry.

[14]  Alfonso Mendoza,et al.  Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis , 2013, ChemMedChem.

[15]  Steven J Novick,et al.  Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG. , 2013, Journal of pharmacological and toxicological methods.

[16]  G. Besra,et al.  University of Birmingham Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors , 2012 .

[17]  S. Cole,et al.  Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1. , 2012, Journal of the American Chemical Society.

[18]  S. Boyce,et al.  Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists. , 2011, Journal of medicinal chemistry.

[19]  F. V. Kieseritzky,et al.  Aziridines in one step from hydantoins via Red-Al mediated ring-contraction , 2011 .

[20]  J. C. Ruble,et al.  Mild Pd-catalyzed N-arylation of methanesulfonamide and related nucleophiles: avoiding potentially genotoxic reagents and byproducts. , 2011, Organic letters.

[21]  Vadim Makarov,et al.  Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis. , 2010, Journal of the American Chemical Society.

[22]  K. Beaumont,et al.  Chapter 2:ADMET for the Medicinal Chemist , 2010 .

[23]  Nicolas Moitessier,et al.  Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors. , 2009, Journal of medicinal chemistry.

[24]  Stewart T. Cole,et al.  Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis , 2009, Science.

[25]  H. Navarro,et al.  Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. , 2009, Journal of medicinal chemistry.

[26]  Albert P. Aldenkamp,et al.  Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: A critical review directed at structural study-bias , 2008, Journal of the Neurological Sciences.

[27]  T. Hiyama,et al.  Cyanoesterification of 1,2-dienes: synthesis and transformations of highly functionalized alpha-cyanomethylacrylate esters. , 2006, Journal of the American Chemical Society.

[28]  John Whittall,et al.  Optimisation and scale-up of microwave assisted cyanation , 2006 .

[29]  Y. Tominaga,et al.  Sythesis of methylthiomaleimides for the preparation of pyridazines and related comopounds , 2002 .

[30]  T. Hughes,et al.  NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)- pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV. , 1999, Biochemistry.

[31]  A. Mancuso,et al.  Oxidation of long-chain and related alcohols to carbonyls by dimethyl sulfoxide "activated" by oxalyl chloride , 1978 .

[32]  C. Pak,et al.  Selective reductions. XIX. Rapid reaction of carboxylic acids with borane-tetrahydrofuran. Remarkably convenient procedure for the selective conversion of carboxylic acids to the corresponding alcohols in the presence of other functional groups , 1973 .

[33]  J. Easton.  Potential hazards of hydantoin use. , 1972, Annals of internal medicine.

[34]  H. Bredereck,et al.  Imidazolsynthesen mit Formamid (Formamid‐Reaktionen, I. Mitteil.) , 1953 .

[35]  H. Bucherer,et al.  Über die Bildung substituierter Hydantoine aus Aldehyden und Ketonen. Synthese von Hydantoinen , 1934 .